The Bioresources team is committed to the reliable progression of the most effective therapeutic candidates into full preclinical development.

All queries regarding bioresources or ethics should be directed to:

About Bioresources

We custom designs studies to screen potential new therapies for the treatment of various neurological disorders. We will help a client develop a tailored selection of the following core platforms with independent, objective clinical and preclinical interpretation: 

  • Imaging and analysis  (Human MRI and PET-CT,  4.7T MRI, Microscopy)
  • Histology
  • Neurological models
  • Behavioural testing services
  • Pharmacokinetics
  • Surgical services
  • Flow cytometry

Animal efficacy models are available in house for studies of Parkinson’s disease, Alzheimer disease, Huntington’s disease, Stroke and Amylotrophic Lateral Sclerosis.

Clients are involved at every stage of a project:

  • Study design and assessment selection
  • Core data feedback to inform further development
  • Interpretation and decision-making

The Florey Animal Ethics Committee (AEC) Terms of Reference and Procedural Guidelines can be found here [PDF]

Support us

Brain health affects all Australians.
You can support our research by making a donation or a bequest.


Latest breakthroughs, news, events & more.